Oct 16, 2021
Dr. Amit Etkin is pioneering a revolution in the way mental health medications are designed, developed, prescribed, and brought to market. Precision psychiatry is the future of mental health treatment and Dr. Etkin is leading the way with his drug development platform, Alto Neuroscience. In this episode, Dr. Etkin explains why psychiatric drugs have failed, what he is doing about it and why it will work.
Prior to Alto Neuroscience, Dr. Etkin was a tenured professor in the Department of Psychiatry and Behavioral Sciences at Stanford University and a member of the Wu Tsai Neurosciences Institute. Dr. Etkin has received multiple awards, most notably the NIH Director’s Pioneer Award in 2017. He is trained as both a psychiatrist and neuroscientist.
The overarching aim of his work in this field for the last 10 years is to understand the neural basis of emotional disorders and their treatment, and to leverage this knowledge to better understand how the brain works and to develop novel treatment interventions. In support of this goal, Dr. Etkin also collaborates with neuroscientists, engineers, psychologists, physicians, and others to establish a new intellectual, scientific, and clinical paradigm for understanding and manipulating human brain circuits in healthy individuals and for treating psychiatric disease.
You can connect with Amit here: LinkedIn
Alto Neuroscience Website: https://www.altoneuroscience.com/
What If Fellowship: https://whatif.vc/fellowship
HERE ARE SOME OF THE THINGS WE TALKED ABOUT:
Connect with host Stephen Hays here: Stephen Hays Personal Website, Twitter, LinkedIn, What If Ventures (Mental Health Venture Fund)